Fluency Endovascular Stent Graft: payments to doctors
Payments that named Fluency Endovascular Stent Graft as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $34K
- Providers
- 620
- Transactions
- 863
- Average per transaction
- $40
The per-transaction average — $40 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 620 providers the average total is $55, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bard Peripheral Vascular, Inc. | $29,491 | 86.4% |
| BD | $4,576 | 13.4% |
| C. R. Bard, Inc. & Subsidiaries | $29 | 0.1% |
| Davol Inc. | $28 | 0.1% |